| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |